Anti-iNOS antibody [EPR16635] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Recombinant Monoclonal iNOS antibody. Carrier free. Suitable for ICC/IF, IP, WB, I-ELISA and reacts with Mouse, Rat, Human, Recombinant fragment - Mouse samples. Cited in 15 publications.
View Alternative Names
NOS2A, NOS2, Hepatocyte NOS, Inducible NO synthase, NOS type II, Peptidyl-cysteine S-nitrosylase NOS2, HEP-NOS, Inducible NOS, iNOS
- WB
Lab
Western blot - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
This data was developed using the same antibody clone in a different buffer formulation (ab178945). Blocking and diluting buffer 5% NFDM/TBST. iNOS is not normally expressed in the brain, but can be induced in the brain after inflammatory, infectious, or other damages (PMID : 11138926, PMID : 16156895, PMID : 10322315).
All lanes:
Western blot - Anti-iNOS antibody [EPR16635] (<a href='/en-us/products/primary-antibodies/inos-antibody-epr16635-ab178945'>ab178945</a>) at 1/1000 dilution
Lane 1:
Mouse hippocampus tissue lysate at 20 µg
Lane 2:
Mouse colon tissue lysate at 20 µg
Lane 3:
Mouse colon cancer tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 131 kDa
false
Exposure time: 180s
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
Immunocytochemistry/Immunofluorescence analysis of RAW 264.7 non-treated and LPS treated (0.1 μg/mL) cells labelling iNOS with ab178945 at 1/250. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. The cells were co-stained with ab195889, Alexa Fluor® 594 conjugated anti-alpha tubulin (1/200). Nuclei counterstained with DAPI (blue).
Secondary antibody only controls performed on non-treated and treated cells.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab178945).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
Clone EPR16635 (ab213987) has been successfully conjugated by Abcam. This image was generated using Anti-iNOS antibody [EPR16635] (Alexa Fluor® 647). Please refer to ab209027 for protocol details.
ab209027 staining iNOS in Raw264.7 cells. The lower panel shows cells treated with 1ug/ml Lipopolysaccharides (24 hr). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab209027at 1/100 dilution (shown in red) and ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 488), at 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue).
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
This product also gave a positive signal under the same testing conditions in SW480 cells fixed with 4% formaldehyde (10 min).
- I-ELISA
Supplier Data
Indirect ELISA - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
ELISA analysis of House mouse iNOS recombinant protein at 1000 ng/mL with ab178945. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab178945).
- IP
Supplier Data
Immunoprecipitation - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
iNOS was immunoprecipitated from 1mg of RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate treated with 1 μg/ml LPS for 24h with ab178945 at 1/100 dilution.
Lane 1 : RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 24h,10ug (Input).
Lane 2 : ab178945 IP in RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 24h.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab178945 in RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 24h.
Western blot was performed from the immunoprecipitate using ab178945 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1500 dilution
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab178945).
All lanes:
Immunoprecipitation - Anti-iNOS antibody [EPR16635] (<a href='/en-us/products/primary-antibodies/inos-antibody-epr16635-ab178945'>ab178945</a>)
Predicted band size: 131 kDa
false
- WB
Supplier Data
Western blot - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab178945).
All lanes:
Western blot - Anti-iNOS antibody [EPR16635] - BSA and Azide free (ab213987) at 1/500 dilution
Lane 1:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
HepG2 (Human hepatocellular carcinoma epithelial cell) treated with 10ug/ml lipopolysaccharides for 6 hours whole cell lysates at 15 µg
Lane 3:
THP-1 (Human monocytic leukemia monocyte) whole cell lysates at 15 µg
Lane 4:
THP-1 (Human monocytic leukemia monocyte) treated with 100ng/ml lipopolysaccharides for 3 hours whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/200000 dilution
Predicted band size: 131 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-iNOS antibody [EPR16635] - BSA and Azide free (AB213987)
Blocking and dilution buffer : 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab178945).
All lanes:
Western blot - Anti-iNOS antibody [EPR16635] - BSA and Azide free (ab213987) at 1/20000 dilution
Lane 1:
Untreated RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate at 20 µg
Lane 2:
RAW 264.7 whole cell lysate treated with 0.1 µg/mL LPS for 6 hours at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution
Predicted band size: 131 kDa
Observed band size: 131 kDa
false
Exposure time: 30s
Related conjugates and formulations (7)
-
Anti-iNOS antibody [EPR16635]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-iNOS antibody [EPR16635]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-iNOS antibody [EPR16635]
-
Anti-iNOS antibody [EPR16635] - Mouse IgG2b (Chimeric) - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-iNOS antibody [EPR16635]
-
Anti-pan NOS antibody [RM1126]
-
Anti-pan NOS antibody [RM1126] - BSA and Azide free
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Product details
ab213987 is the carrier-free version of ab178945.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
INOS plays a significant role in the immune system by participating in the defense against pathogens. The enzyme is part of a molecular complex that generates NO which acts as a signaling molecule and has antimicrobial properties. iNOS activity is induced during immune responses and contributes to the elimination of bacteria and viruses through the production of reactive nitrogen species. Its expression is tightly regulated by cytokines and other signaling molecules that modulate the extent of its action.
Pathways
INOS integrates into the nitric oxide signaling pathway and is closely associated with inflammatory pathways. NO serves as a messenger within the nitric oxide signaling pathway facilitating processes like vasodilation and neurotransmission. iNOS works alongside other proteins such as cytokines like interferon-gamma that elevate its activity during inflammation and immune responses. The regulation of iNOS expression and activity plays an essential role in maintaining immune homeostasis and ensuring proper response to infections.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Journal of orthopaedic surgery and research 17:232 PubMed35414033
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:4835-4843 PubMed34150065
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature cancer 2:545-562 PubMed35122017
2021
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 8:1181 PubMed33241030
2020
Applications
Unspecified application
Species
Unspecified reactive species
Histology and histopathology :18278 PubMed33146403
2020
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 264:118658 PubMed33115604
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:20184-20197 PubMed33099539
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 20:159 PubMed33093897
2020
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical jo 26:e921957 PubMed32463805
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 46:718-728 PubMed32468025
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Primary Antibodies
AB205529
Anti-iNOS antibody [EPR16630]
primary-antibodies
inos-antibody-epr16630-ab205529
3
(1 reviews)
Alternative Product
Primary Antibodies
AB202417
Anti-iNOS+nNOS antibody [EP16634]
primary-antibodies
inosnnos-antibody-ep16634-ab202417
4
(1 reviews)
Alternative Version
Primary Antibodies
AB209594
Alexa Fluor® 555 Anti-iNOS antibody [EPR16635]
primary-antibodies
alexa-fluor-555-inos-antibody-epr16635-ab209594
0
(0 reviews)
Alternative Version
Primary Antibodies
AB209595
Alexa Fluor® 568 Anti-iNOS antibody [EPR16635]
primary-antibodies
alexa-fluor-568-inos-antibody-epr16635-ab209595
0
(0 reviews)
Alternative Version
Primary Antibodies
AB209027
Alexa Fluor® 647 Anti-iNOS antibody [EPR16635]
primary-antibodies
alexa-fluor-647-inos-antibody-epr16635-ab209027
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com